Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy
出版年份 2014 全文链接
标题
Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy
作者
关键词
Immunocytokines, Interleukin-2, Oncofetal fibronectin, Vascular targeting
出版物
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 63, Issue 9, Pages 901-910
出版商
Springer Nature
发表日期
2014-06-03
DOI
10.1007/s00262-014-1562-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The antibody-based targeted delivery of TNF in combination with doxorubicin eradicates sarcomas in mice and confers protective immunity
- (2013) T Hemmerle et al. BRITISH JOURNAL OF CANCER
- The antibody-based targeted delivery of interleukin-4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancer
- (2013) Teresa Hemmerle et al. INTERNATIONAL JOURNAL OF CANCER
- Phase 0 Microdosing PET Study Using the Human Mini Antibody F16SIP in Head and Neck Cancer Patients
- (2013) D. A. Heuveling et al. JOURNAL OF NUCLEAR MEDICINE
- Pharmacotherapy of metastatic melanoma: Emerging trends and opportunities for a cure
- (2013) Francesca Pretto et al. PHARMACOLOGY & THERAPEUTICS
- Antibody–cytokine fusion proteins
- (2012) Roland E. Kontermann ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Paclitaxel Enhances Therapeutic Efficacy of the F8-IL2 Immunocytokine to EDA-Fibronectin-Positive Metastatic Human Melanoma Xenografts
- (2012) M. Moschetta et al. CANCER RESEARCH
- The Antibody-Based Delivery of Interleukin-12 to the Tumor Neovasculature Eradicates Murine Models of Cancer in Combination with Paclitaxel
- (2012) N. Pasche et al. CLINICAL CANCER RESEARCH
- Immunocytokines: a novel class of potent armed antibodies
- (2012) Nadine Pasche et al. DRUG DISCOVERY TODAY
- A phase I dose-escalation study of the immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumours
- (2012) Silke Gillessen et al. EUROPEAN JOURNAL OF CANCER
- Phase I/II study of the tumour-targeting human monoclonal antibody–cytokine fusion protein L19-TNF in patients with advanced solid tumours
- (2012) G. Spitaleri et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis
- (2012) Benjamin Weide et al. JOURNAL OF CLINICAL ONCOLOGY
- The Immunocytokine L19–IL2 Eradicates Cancer When Used in Combination with CTLA-4 Blockade or with L19-TNF
- (2012) Kathrin Schwager et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Radioimmunotherapy with Radretumab in Patients with Relapsed Hematologic Malignancies
- (2012) P. A. Erba et al. JOURNAL OF NUCLEAR MEDICINE
- Local and intralesional therapy of in-transit melanoma metastases
- (2012) Alessandro Testori et al. JOURNAL OF SURGICAL ONCOLOGY
- Isolated limb perfusion with the tumor-targeting human monoclonal antibody-cytokine fusion protein L19-TNF plus melphalan and mild hyperthermia in patients with locally advanced extremity melanoma
- (2012) Francesco Papadia et al. JOURNAL OF SURGICAL ONCOLOGY
- A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma
- (2011) T. K. Eigentler et al. CLINICAL CANCER RESEARCH
- Different patterns of fibronectin and tenascin-C splice variants expression in primary and metastatic melanoma lesions
- (2011) Katharina Frey et al. EXPERIMENTAL DERMATOLOGY
- The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model
- (2011) Kathrin Schwager et al. HUMAN REPRODUCTION
- A comparative immunofluorescence analysis of three clinical-stage antibodies in head and neck cancer
- (2011) Kathrin Schwager et al. Head and Neck Optical Diagnostics Society
- Combination of temozolomide with immunocytokine F16–IL2 for the treatment of glioblastoma
- (2010) M Pedretti et al. BRITISH JOURNAL OF CANCER
- High response rate after intratumoral treatment with interleukin-2
- (2010) Benjamin Weide et al. CANCER
- Survival after intratumoral interleukin-2 treatment of 72 melanoma patients and response upon the first chemotherapy during follow-up
- (2010) Benjamin Weide et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma
- (2010) Manfred Johannsen et al. EUROPEAN JOURNAL OF CANCER
- The Immunocytokine F8-IL2 Improves the Therapeutic Performance of Sunitinib in a Mouse Model of Renal Cell Carcinoma
- (2010) Katharina Frey et al. JOURNAL OF UROLOGY
- Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients
- (2009) S. Sauer et al. BLOOD
- Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis
- (2009) Kathrin Schwager et al. ARTHRITIS RESEARCH & THERAPY
- Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2
- (2008) C. Schliemann et al. BLOOD
- Antibody-Mediated Delivery of Interleukin-2 to the Stroma of Breast Cancer Strongly Enhances the Potency of Chemotherapy
- (2008) J. Marlind et al. CLINICAL CANCER RESEARCH
- Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Conjunction with Vaccines
- (2008) F. O. Smith et al. CLINICAL CANCER RESEARCH
- A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculaturein vivo
- (2008) Alessandra Villa et al. INTERNATIONAL JOURNAL OF CANCER
- Adverse Consequences of Immunostimulation
- (2008) Rafael Ponce Journal of Immunotoxicology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started